PI Financial Special Situations Equity Analyst Jason Zandberg reiterated an Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF) (FRA:21P) alongside a ‘buy’ rating of $13 CAD per share. Auroraβs numerous acquisitions, most notably MedReleaf Corp. (TSX:LEAF), their critical mass of production, and sales growth are all catalysts for their future valuation. Zandberg believes βits a great time to be buying Aurora in this dipβ as the company is nearing a mass inflection point of support in their share price.
Get Real-Time Updates from MJobserver.com